查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828178

2025年全球转染试剂和设备市场报告

Transfection Reagents And Equipment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，转染试剂和仪器市场呈现强劲成长势头，市场规模从2024年的15.8亿美元成长至2025年的17.4亿美元，复合年增长率达9.8%。预测期内的成长归因于生物医学研究、药物开发、日益增长的生物技术应用、学术研究机构以及基因工程技术的进步。

预计未来几年转染试剂和设备市场将快速成长，到2029年将达到26.6亿美元，复合年增长率为11.2%。预测期内的成长归因于基因治疗的进步、生物製造需求的不断增长、新兴的细胞疗法、个人化医疗的研发以及全球研究合作。预测期内的主要趋势包括：对初代细胞转染的关注、向电穿孔技术的转变、奈米技术在转染中的应用、对无动物源转染试剂的需求不断增长，以及自动化和高性能转染系统。

转染试剂是用于将外来遗传物质（例如 DNA 或 RNA）导入细胞的物质或套件。这些试剂有助于将核酸递送到细胞中，在研究人员探索基因表现、调控基因功能和生产重组蛋白方面发挥重要作用。

在转染试剂和设备领域，主要类别包括仪器、试剂和套件。转染设备是专门设计的实验室设备，用于在转染过程中有效地将外来核酸（例如 DNA 或 RNA）递送到细胞中。所涉及的分子包括质体DNA、DNA 寡核苷酸、小干扰 RNA (siRNA)、蛋白质和核糖核蛋白复合物 (RNP)。多种生物体，包括细菌、哺乳动物细胞、真菌、植物和病毒，都可以作为这些分子的受体。这些产品适用于各种最终用户，包括生物製药公司、委外研发机构(CRO)、合约製造组织 (CMO)、合约研究、开发和製造组织 (CDMO)、大学、医院和临床实验室。

2025年春季美国关税突然上调及其引发的贸易摩擦，对医疗设备领域产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供转染试剂和仪器市场统计数据，例如全球市场规模、各地区份额、竞争对手的市场份额、详细的转染试剂和仪器细分市场、市场趋势以及转染试剂和仪器行业的商机，为您提供在转染试剂和仪器行业取得成功所需的数据。本转染试剂和仪器市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供全面观点所需的一切。

未来五年的预测成长率为11.2%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会英国影响美国，导致来自英国和新加坡等主要地区的脂质奈米颗粒和电穿孔比色皿供应链中断，这可能导致基因治疗研发的延迟。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响可能会更加广泛地显现出来。

全球癌症发生率的上升预计将推动转染试剂和仪器市场的扩张。癌症是指细胞异常且不受控制的增生。转染试剂在质体研究中发挥着至关重要的作用，它使研究人员能够透过引入外来遗传物质（如质粒 DNA 和 RNA 分子）来研究癌症生物学的各个方面，包括基因基因表现研究、基因静默、药物筛检和标靶检验。例如，美国非营利组织美国癌症协会于 2024 年 4 月报告称，2022 年将新增 2,000 万例癌症病例，并将有 970 万人死亡。因此，全球癌症患者数量的增加正在刺激转染试剂和仪器市场的成长。

医疗保健支出的成长趋势预计将在短期内推动转染试剂和仪器市场的成长。医疗保健支出包括与提供医疗服务、计划生育活动、营养计划和以健康为重点的紧急援助有关的所有费用。医疗保健支出的增加导致研发投资的增加，从而推动了对转染试剂和仪器的需求，因为它们是推动基因研究、基因治疗和生物製药开发的重要工具。例如，截至 2023 年 6 月，美国联邦机构医疗保险和医疗补助服务中心报告称，到 2021 年，美国的医疗保健支出将增加 2.7%，达到 4.3 兆美元，即人均 12,914 美元。这项支出占国内生产总值的 18.3%。因此，医疗保健支出的快速成长正在推动转染试剂和仪器市场的成长。

产品创新是推动转染试剂和仪器市场发展的突出趋势，主要企业专注于策略性地开发原创产品以保持其市场地位。例如，总部位于法国的生技公司Polyplus-Transfection SA于2022年9月推出了in vivo-jet-RNA+转染试剂。这款新产品利用预製脂质体製剂进行体内mRNA递送，是一种高效且可扩展的基因递送系统，能够将mRNA递送送到多种组织和细胞类型中。该试剂安全且耐受性良好，无需配製步骤，其稳定的脂质体尺寸允许mRNA浓度随时间变化。其治疗包括预防性疫苗接种、mRNA疗法（用于癌症治疗、罕见疾病等）以及基因编辑。

转染试剂和设备市场的主要企业正在加紧努力推出创新产品线。美国生技公司Mirus Bio LLC于2022年8月推出其TransIT-VirusGEN GMP产品线，体现了这项做法。此产品线专为高效、可扩展的病毒载体转染而设计，并支援基因治疗应用的GMP生产流程。 TransIT-VirusGEN GMP转染试剂专用腺结合病毒(AAV)和慢病毒载体的大规模治疗性生产，可作为多种产品（包括细胞、基因和组织工程产品）的辅助材料，符合USP <1043标准。其主要目标是帮助生物製药製造商应对与有效且经济地生产符合商业性可行性要求的品质和数量的AAV和LV载体相关的挑战。

2023年3月，德国分析仪器製造商赛多利斯公司（Sartorius AG）以26亿美元收购了Polyplus-Transfection SA。此次收购使赛多利斯公司在快速扩张的细胞和基因治疗市场中占据了有利地位，支持其业务成长并满足日益增长的细胞和基因治疗需求。 Polyplus-Transfection SA是一家法国生物技术公司，专注于转染试剂和仪器的开发。

转染试剂和设备市场的主要企业包括 Thermo Fisher Scientific Inc.、Promega Corporation、Qiagen NV、Bio-Rad Laboratories Inc.、Maxcyte Inc.、Lonza Group Ltd.、Merck KGaA、Mirus Bio LLC、OriGene Technologies Inc.、PromoCell GmbH、Perkinerial Inc.、Alkin Technologies Inc. Ltd.、Sartorius AG、Takara Bio Inc.、Tecan Trading AG、Polyplus-transfection SA、Sigma-Aldrich Corporation、Hoffmann-La Roche Ltd.、Transfection Technologies Inc.、Viromer、ABM Inc.、Bio-Techne Corporation、BIoTium Inc.、Cell Applications Inc.、Genchemel、Hkaks、Hun​​ions Gmbent、Hendakes Bioscience GmbH。

2024年，北美是转染试剂和仪器市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。转染试剂和仪器市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

转染试剂和设备市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、美国、英国、加拿大、义大利、西班牙

转染试剂和设备市场包括脂质体转染试剂、阳离子聚合物转染试剂、磷酸钙转染试剂、病毒递送工具、转染对照质体、转染检验工具和电穿孔系统的销售。该市场的价值是指“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场商品的价值还包括创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球转染试剂与设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球转染试剂和仪器市场：成长率分析
  • 全球转染试剂与仪器市场表现：规模与成长，2019-2024
  • 全球转染试剂与仪器市场预测：规模与成长，2024-2029，2034
  • 全球转染试剂与仪器：总目标市场（TAM）

第六章 市场细分

  • 全球转染试剂和仪器市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂和套件
  • 全球转染试剂和仪器市场（按分子类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 质体DNA
  • DNA寡核苷酸
  • 小干扰RNA（SiRNA）
  • 蛋白质
  • 核糖核蛋白复合体（RNP）
  • 其他的
  • 全球转染试剂和仪器市场（按生物学、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 细菌
  • 哺乳动物细胞
  • 真菌
  • 植物
  • 病毒
  • 全球转染试剂和仪器市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 生物製药
  • 合约研究组织（CRO）
  • 契约製造组织 (CMO) 和合约开发和製造组织 (CDMO)
  • 学术界
  • 医院
  • 临床实验室
  • 其他的
  • 全球转染试剂和仪器市场：仪器细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 电穿孔系统
  • 显微注射系统
  • 粒子撞击系统
  • 其他的
  • 全球转染试剂和仪器市场：试剂和套件细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 脂质转染试剂
  • 以聚合物为基础的转染试剂
  • 基于蛋白质的转染试剂
  • 核酸递送试剂套件
  • 其他的

第七章 区域和国家分析

  • 全球转染试剂和仪器市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球转染试剂及仪器市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 转染试剂与仪器市场：竞争格局
  • 转染试剂和仪器市场：公司简介
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Qiagen NV
    • Bio-Rad Laboratories Inc.
    • Maxcyte Inc.

第31章：其他领先和创新企业

  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • OriGene Technologies Inc.
  • PromoCell GmbH
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • Altogen Biosystems
  • Applied Biological Materials Inc.
  • Bex Co. Ltd.
  • Sartorius AG
  • Takara Bio Inc.
  • Tecan Trading AG
  • Polyplus-transfection SA
  • Sigma-Aldrich Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年转染试剂和仪器市场：提供新机会的国家
  • 2029年转染试剂和仪器市场：细分市场带来新机会
  • 2029年转染试剂与仪器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24564u

Transfection reagents are substances or kits employed for introducing foreign genetic material, such as DNA or RNA, into cells. These reagents play a crucial role in facilitating the delivery of nucleic acids into cells, enabling researchers to explore gene expression, manipulate gene function, or produce recombinant proteins.

Within the realm of transfection reagents and equipment, the primary categories encompass instruments and reagents, along with kits. Transfection instruments are specialized laboratory tools designed to streamline the delivery of foreign nucleic acids, such as DNA or RNA, into cells during the transfection process. The range of molecules involved includes plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs), and others. Various organisms, including bacteria, mammalian cells, fungi, plants, and viruses, serve as recipients for these molecules. These products find application across diverse end-users, including biopharma, contract research organizations (CROs), contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), academia, hospitals, clinical labs, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The transfection reagents and equipment market research report is one of a series of new reports from The Business Research Company that provides transfection reagents and equipment market statistics, including transfection reagents and equipment industry global market size, regional shares, competitors with a transfection reagents and equipment market share, detailed transfection reagents and equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the transfection reagents and equipment industry. This transfection reagents and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transfection reagents and equipment market size has grown strongly in recent years. It will grow from $1.58 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to biomedical research demand, pharmaceutical development, rise in biotechnology applications, academic and research institutions, genetic engineering advancements.

The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to $2.66 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to gene therapy advancements, increasing bioproduction needs, emerging cell-based therapies, r&d in personalized medicine, global collaborations. Major trends in the forecast period include focus on primary cell transfection, shift towards electroporation techniques, integration of nanotechnology in transfection, increasing demand for animal-free transfection reagents, automation and high-throughput transfection systems.

The forecast of 11.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for lipid nanoparticles and electroporation cuvettes, sourced from key regions such as the United Kingdom and Singapore, could lead to research delays in gene therapy development.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing global incidence of cancer is expected to drive the expansion of the transfection reagents and equipment market. Cancer is defined by the abnormal and uncontrolled proliferation of cells. Transfection reagents play a crucial role in cancer research by introducing foreign genetic material, such as plasmid DNA or RNA molecules, allowing researchers to investigate various aspects of cancer biology, including gene expression studies, gene silencing, drug screening, and target validation. For instance, in April 2024, the American Cancer Society, a US-based non-profit organization, reported 20 million new cancer cases and 9.7 million deaths in 2022. Consequently, the increasing number of cancer patients worldwide is fueling the growth of the transfection reagents and equipment market.

The upward trajectory in healthcare expenditures is expected to fuel the growth of the transfection reagents and equipment market in the foreseeable future. Healthcare expenditures encompass all costs associated with delivering health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. The increase in healthcare spending translates to higher investments in research and development, thereby boosting the demand for transfection reagents and equipment as indispensable tools for advancing genetic research, gene therapy, and biopharmaceutical development. For instance, as of June 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported a 2.7% increase in healthcare expenditure in the United States, totaling $4.3 trillion or $12,914 per person in 2021. This expenditure accounted for 18.3% of the nation's gross domestic product. Consequently, the surge in healthcare expenditures is a driving force behind the growth of the transfection reagents and equipment market.

A prominent trend gaining traction in the transfection reagents and equipment market is product innovation, with major companies strategically focusing on developing inventive products to maintain their market standing. An example of this is Polyplus-Transfection SA, a France-based biotechnology company, which, in September 2022, introduced the in vivo-jetRNA+ transfection reagent. This novel product utilizes a preformed liposome formulation for in vivo mRNA delivery, offering a highly efficient and scalable gene delivery system capable of delivering mRNA to diverse tissues and cell types. Notably safe and well-tolerated, the reagent eliminates the need for formulation stages, and its stable liposome size accommodates varying mRNA concentrations over time. Applications include prophylactic vaccinations, mRNA treatments (such as cancer therapy and rare diseases), and gene editing.

Major companies in the transfection reagents and equipment market are intensifying their efforts to introduce innovative product lines. Mirus Bio LLC, a US-based biotechnology company, exemplifies this approach with the launch of the TransIT-VirusGEN GMP product line in August 2022. This product line, designed for efficient and scalable transfection of viral vectors, supports GMP manufacturing processes in gene therapy applications. Specifically tailored for large-scale therapeutic production of adeno-associated virus (AAV) and lentivirus vectors, the TransIT-VirusGEN GMP Transfection Reagent serves as an ancillary material for various products, including cell, gene, and tissue-engineered products, meeting USP <1043 standards. The primary goal is to aid biopharmaceutical manufacturers in addressing challenges related to effectively and cost-effectively producing AAV and LV vectors with the requisite quality and volume for commercial viability.

In March 2023, Sartorius AG, a Germany-based analytical laboratory instrument manufacturing company, acquired Polyplus-Transfection SA for $2.6 billion. This acquisition positions Sartorius AG strongly in the rapidly expanding cell and gene therapy markets, supporting business growth and meeting the escalating demand for cell and gene therapies. Polyplus-Transfection SA, a France-based biotechnology company, specializes in the development of transfection reagents and equipment.

Major companies operating in the transfection reagents and equipment market include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Genlantis, Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH

North America was the largest region in the transfection reagents and equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the transfection reagents and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transfection reagents and equipment market consists of sales of lipid-based transfection reagents, cationic polymer-based transfection reagents, calcium phosphate-based transfection reagents, viral transduction tools, transfection control plasmids, transfection validation tools, and electroporation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transfection Reagents And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transfection reagents and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transfection reagents and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transfection reagents and equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Products: Instruments; Reagent And Kits
  • 2) By Types Of Molecule: Plasmid DNA; DNA Oligonucleotides; Small Interfering RNA (SiRNA); Proteins; Ribonucleoprotein Complexes (RNPs); Other Molecules
  • 3) By Organism: Bacteria; Mammalian Cells; Fungi; Plants; Virus
  • 4) By End User: Biopharma; Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs); Academia; Hospitals; Clinical Labs; Other End Users
  • Subsegments:
  • 1) By Instruments: Electroporation Systems; Microinjection Systems; Particle Bombardment Systems; Other Instruments
  • 2) By Reagent And Kits: Lipid-Based Transfection Reagents; Polymer-Based Transfection Reagents; Protein-Based Transfection Reagents; Nucleic Acid Delivery Kits; Other Reagents And Kits
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Promega Corporation; Qiagen N.V.; Bio-Rad Laboratories Inc.; Maxcyte Inc.; Lonza Group Ltd.; Merck KGaA; Mirus Bio LLC; OriGene Technologies Inc.; PromoCell GmbH; PerkinElmer Inc.; Agilent Technologies Inc.; Altogen Biosystems; Applied Biological Materials Inc.; Bex Co. Ltd.; Sartorius AG; Takara Bio Inc.; Tecan Trading AG; Polyplus-transfection SA; Sigma-Aldrich Corporation; Hoffmann-La Roche Ltd.; Transfection Technologies Inc.; Viromer; ABM Inc.; Bio-Techne Corporation; Biotium Inc.; Cell Applications Inc.; chemicell GmbH; Genlantis; Biontex Laboratories GmbH; Boca Scientific Inc.; Jena Bioscience GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transfection Reagents And Equipment Market Characteristics

3. Transfection Reagents And Equipment Market Trends And Strategies

4. Transfection Reagents And Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Transfection Reagents And Equipment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transfection Reagents And Equipment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transfection Reagents And Equipment Market Growth Rate Analysis
  • 5.4. Global Transfection Reagents And Equipment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transfection Reagents And Equipment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transfection Reagents And Equipment Total Addressable Market (TAM)

6. Transfection Reagents And Equipment Market Segmentation

  • 6.1. Global Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagent And Kits
  • 6.2. Global Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasmid DNA
  • DNA Oligonucleotides
  • Small Interfering RNA (SiRNA)
  • Proteins
  • Ribonucleoprotein Complexes (RNPs)
  • Other Molecules
  • 6.3. Global Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Mammalian Cells
  • Fungi
  • Plants
  • Virus
  • 6.4. Global Transfection Reagents And Equipment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharma
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs)
  • Academia
  • Hospitals
  • Clinical Labs
  • Other End Users
  • 6.5. Global Transfection Reagents And Equipment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electroporation Systems
  • Microinjection Systems
  • Particle Bombardment Systems
  • Other Instruments
  • 6.6. Global Transfection Reagents And Equipment Market, Sub-Segmentation Of Reagent And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lipid-Based Transfection Reagents
  • Polymer-Based Transfection Reagents
  • Protein-Based Transfection Reagents
  • Nucleic Acid Delivery Kits
  • Other Reagents And Kits

7. Transfection Reagents And Equipment Market Regional And Country Analysis

  • 7.1. Global Transfection Reagents And Equipment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transfection Reagents And Equipment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transfection Reagents And Equipment Market

  • 8.1. Asia-Pacific Transfection Reagents And Equipment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transfection Reagents And Equipment Market

  • 9.1. China Transfection Reagents And Equipment Market Overview
  • 9.2. China Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transfection Reagents And Equipment Market

  • 10.1. India Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transfection Reagents And Equipment Market

  • 11.1. Japan Transfection Reagents And Equipment Market Overview
  • 11.2. Japan Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transfection Reagents And Equipment Market

  • 12.1. Australia Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transfection Reagents And Equipment Market

  • 13.1. Indonesia Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transfection Reagents And Equipment Market

  • 14.1. South Korea Transfection Reagents And Equipment Market Overview
  • 14.2. South Korea Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transfection Reagents And Equipment Market

  • 15.1. Western Europe Transfection Reagents And Equipment Market Overview
  • 15.2. Western Europe Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transfection Reagents And Equipment Market

  • 16.1. UK Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transfection Reagents And Equipment Market

  • 17.1. Germany Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transfection Reagents And Equipment Market

  • 18.1. France Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transfection Reagents And Equipment Market

  • 19.1. Italy Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transfection Reagents And Equipment Market

  • 20.1. Spain Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transfection Reagents And Equipment Market

  • 21.1. Eastern Europe Transfection Reagents And Equipment Market Overview
  • 21.2. Eastern Europe Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transfection Reagents And Equipment Market

  • 22.1. Russia Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transfection Reagents And Equipment Market

  • 23.1. North America Transfection Reagents And Equipment Market Overview
  • 23.2. North America Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transfection Reagents And Equipment Market

  • 24.1. USA Transfection Reagents And Equipment Market Overview
  • 24.2. USA Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transfection Reagents And Equipment Market

  • 25.1. Canada Transfection Reagents And Equipment Market Overview
  • 25.2. Canada Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transfection Reagents And Equipment Market

  • 26.1. South America Transfection Reagents And Equipment Market Overview
  • 26.2. South America Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transfection Reagents And Equipment Market

  • 27.1. Brazil Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transfection Reagents And Equipment Market

  • 28.1. Middle East Transfection Reagents And Equipment Market Overview
  • 28.2. Middle East Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transfection Reagents And Equipment Market

  • 29.1. Africa Transfection Reagents And Equipment Market Overview
  • 29.2. Africa Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transfection Reagents And Equipment Market Competitive Landscape And Company Profiles

  • 30.1. Transfection Reagents And Equipment Market Competitive Landscape
  • 30.2. Transfection Reagents And Equipment Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Maxcyte Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Transfection Reagents And Equipment Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd.
  • 31.2. Merck KGaA
  • 31.3. Mirus Bio LLC
  • 31.4. OriGene Technologies Inc.
  • 31.5. PromoCell GmbH
  • 31.6. PerkinElmer Inc.
  • 31.7. Agilent Technologies Inc.
  • 31.8. Altogen Biosystems
  • 31.9. Applied Biological Materials Inc.
  • 31.10. Bex Co. Ltd.
  • 31.11. Sartorius AG
  • 31.12. Takara Bio Inc.
  • 31.13. Tecan Trading AG
  • 31.14. Polyplus-transfection SA
  • 31.15. Sigma-Aldrich Corporation

32. Global Transfection Reagents And Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transfection Reagents And Equipment Market

34. Recent Developments In The Transfection Reagents And Equipment Market

35. Transfection Reagents And Equipment Market High Potential Countries, Segments and Strategies

  • 35.1 Transfection Reagents And Equipment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transfection Reagents And Equipment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transfection Reagents And Equipment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer